SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
RNAi
An SI Board Since May 2003
Posts SubjectMarks Bans
671 52 0
Emcee:  tuck Type:  Unmoderated
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
521CHICAGO, Jan 9 (Reuters) - Pfizer Inc.(PFE.N: Quote, Profile , Research) has entkeokalani'nui-1/9/2007
520Interesting discovery from Hopkins, "cellular zip codes" -- will be inThomas-1/4/2007
519Just a little heads-up: Nucleonics, Inc, a PA-based RNAi company plans on submixw2k-12/25/2006
518Thanks, Nigel. Sounds encouraging. Here is a USA Today recap of thte Sirna stoThomas-11/30/2006
517SR Pharma plc Announces Superior Therapeutic Efficacy of Atu027 RNAi in nigel bates-11/29/2006
516Isis and Alnylam Announce Issued U.S. Patent Broadly Covering Chemical Modificatnigel bates-11/27/2006
515>>I can keep going.<< So can SR - another 20% today. London 16 Novnigel bates-11/17/2006
514I think IB lets you buy stocks around the world from an online trading account. Ian@SI-11/16/2006
513Schwab will trade in London. You can't do it online, but it's only a phA.J. Mullen-11/16/2006
51217m cap. is way out of date. They had 93m shares in issue, plus the recent 20m nigel bates-11/16/2006
511Hi Nigel, Surprising that they only have a 17mm GBP market cap. SR Pharma boughThomas-11/16/2006
510Hi Nigel, Surprising that they only have a 17mm GBP market cap. SR Pharma boughThomas-11/16/2006
509Go to the back of the line. I sold OMRI thinking to buy back in lower and it iskenhott-11/16/2006
508>>SR Pharma... FWIW, I'm out for now<< Shows how smart I am - unigel bates-11/16/2006
507SR Pharma... <i>FWIW, I'm out for now, as a fund raising @19p (for fanigel bates-11/13/2006
506<b>RNAi According to Stephen Quay</b> (CEO of NSTK): investorshub.cDewDiligence_on_SI-11/9/2006
505Senetek is a profitable company now and the revenue stream will be increasing frjh2006-11/8/2006
504RNA synthetic biology Farren J Isaacs1, Daniel J Dwyer2,3 & James J Collinnigel bates-11/7/2006
503pipeline.corante.com ...Here's a perfect example, since I was just expressinigel bates-11/7/2006
502Thanks much for posting the link.BulbaMan-11/6/2006
501Alnylam: Validated… or Spurned? investorshub.comDewDiligence_on_SI-11/6/2006
50009:42 am Alnylam Pharmaceuticals: Bear Stearns downgrades Outperform to Peer PerIan@SI-11/3/2006
499How come the guys at Galenea didn't work at ALNY? Why a new company? Any potechnetium-11/2/2006
498That’s typical Quay all the way!DewDiligence_on_SI-10/31/2006
497lol. Good one. They were a little late, next time 7am would be better. I gueskenhott-10/31/2006
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):